Established in 1993 by Raimund Mannhold, Povl Krogsgaard-Larsen and Hendrik Timmerman, authors and editors in the series have come from the pharmaceutical industry as well as from academic institutions, fostering a more active exchange between these realms. Find out more about the current Series Editors below.
Raimund Mannhold is an emeritus Professor for Molecular Drug Research at the Heinrich-Heine-University of Düsseldorf; he is a founding editor of this book series. His main research interests comprise 3D-QSAR and virtual screening studies in the fields of ion channel ligands as well as anti-cancer cell death inducers and calculation methods for physico-chemical drug properties.
Helmut Buschmann has a PhD in organic chemistry from Aachen University and extensive industrial experience in medicinal chemistry, drug discovery and development, scale-up, pharmaceutical development, CMC, patent filing and prosecution. He has over 25 years of international experience in the pharmaceutical/biotechnology sectors, both in industry and academia. During his career he worked with a broad range of different targets in different therapeutic areas from pain research to anti-infectives.
Jörg Holenz heads GlaxoSmithKline?s Neuroscience Discovery Performance Unit in Upper Providence, Pennsylvania, USA. As a passionate Medicinal Chemist and Research Leader with more than 20 years of experience, he has delivered numerous clinical candidates in the pain and neuroscience disease areas.